COLOPLAST SP.ADR 1/10 DK1 (CBH) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.162x

Based on the latest financial reports, COLOPLAST SP.ADR 1/10 DK1 (CBH) has a cash flow conversion efficiency ratio of 0.162x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.23 Billion ≈ $2.61 Billion USD) by net assets (€13.80 Billion ≈ $16.14 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CBH cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

COLOPLAST SP.ADR 1/10 DK1 - Cash Flow Conversion Efficiency Trend (2021–2024)

This chart illustrates how COLOPLAST SP.ADR 1/10 DK1's cash flow conversion efficiency has evolved over time, based on yearly financial data.

COLOPLAST SP.ADR 1/10 DK1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of COLOPLAST SP.ADR 1/10 DK1 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
BridgeBio Pharma Inc
NASDAQ:BBIO
0.057x
Gfl Environmental Holdings Inc
TO:GFL
0.021x
ALTEOGEN Inc
KQ:196170
0.041x
Smith & Nephew SNATS Inc
NYSE:SNN
0.168x
Logitech International S.A.
SW:LOGN
0.089x
TFI International Inc
TO:TFII
0.045x
GRAB HOLDINGS LTD CL.A
F:A6I
0.010x
Guardant Health Inc
NASDAQ:GH
0.362x

Annual Cash Flow Conversion Efficiency for COLOPLAST SP.ADR 1/10 DK1 (2021–2024)

The table below shows the annual cash flow conversion efficiency of COLOPLAST SP.ADR 1/10 DK1 from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of COLOPLAST SP.ADR 1/10 DK1.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-09-30 €17.94 Billion
≈ $20.98 Billion
€2.77 Billion
≈ $3.23 Billion
0.154x -36.89%
2023-09-30 €17.30 Billion
≈ $20.22 Billion
€4.23 Billion
≈ $4.94 Billion
0.244x -60.27%
2022-09-30 €8.29 Billion
≈ $9.69 Billion
€5.10 Billion
≈ $5.96 Billion
0.615x -5.05%
2021-09-30 €8.17 Billion
≈ $9.55 Billion
€5.29 Billion
≈ $6.18 Billion
0.648x --

About COLOPLAST SP.ADR 1/10 DK1

F:CBH Germany Medical Instruments & Supplies
Market Cap
$13.33 Billion
€11.41 Billion EUR
Market Cap Rank
#1877 Global
#390 in Germany
Share Price
€5.50
Change (1 day)
-1.79%
52-Week Range
€5.50 - €9.50
All Time High
€15.64
About

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more